Expedite All Remdesivir Black Marketing Cases, HC To Trial Courts

Nagpur: The Nagpur bench of Bombay high court on Friday directed all trial courts to dispose of cases related to black marketing of Remdesivir, used for treating critically ill Covid patients, on merit as expeditiously as possible.

“We are issuing these directives with the hope that expression “as expeditiously as possible” would not be misunderstood as granting infinite time in the matter. The directives have been passed afresh as the time limit set earlier by this court has seen its expiry long back,” said a division bench comprising Justice Sunil Shukre and Justice Anil Kilor.

While disposing of suo motu application regarding delay in completing trials related to Remdesivir black marketing cases, the bench relied upon probe report filed by sessions judge and affidavit filed by amicus curiae Shreerang Bhandarkar, who clarified that the presiding officers had no role in the delay, but it was caused due to variety of factors.

“Overall, upon consideration of sessions judge report, Roznamas of all the cases, and also the amicus’s affidavit, we find that no blame could be placed on the shoulders of any of the presiding officers in conduct of trials,” said the judges.

“No doubt, Maharashtra government complied with the directives issued by HC in appointing a special prosecutor (Jyoti Vajani) without delay. But, such a prompt step did not prove to be effective in the face of various challenges that arose and dealt with by the presiding officer, some of which were narrated earlier,” they added.

On June 22, the HC had expressed anguish over the delay in trials and ordered a “fact-finding” probe against former and current sessions judges, presiding over them.

On Friday, the justices said after going through the sessions judge’s report and also copies of the daily order-sheets, they found that there were several factors which contributed to the delay in disposal of several cases which were committed quite promptly by the judicial magistrates to the concerned judges.

“One of the factors indicated that HC order was challenged by some accused before the Supreme Court. Although accused persons did not place on record any details of the challenge so made before the trial court, it was quite natural for the presiding officer to have hesitated to proceed with the trial,” they said.

  • Related Posts

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    New Delhi: The Parliamentary Panel on Health and Family Welfare has recommended various significant regulatory changes in the regulation of medical devices, including decentralisation of approval for all medical devices…

    Diabetic drug metformin found to act on brain

    NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory